SNAG and SNME in Non-Specific Sciatic Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-50
SponsorIstinye University
About this trial
This study is designed as a crossover trial. All participants who meet the inclusion criteria and voluntarily agree to participate will be evaluated using the assessment methods detailed below. Subsequently, participants will be randomly assigned into two groups. The first group (Mulligan Concept Group - MCG) will receive the SNAG technique, while the second group (Neural Mobilization Group - NMG) will perform the Sciatic Nerve Mobilization Exercise (SNME). After the intervention, participants will be evaluated a second time. Ten days after this session, participants will be invited back. Those who were in the MCG group during the first session will be re-evaluated and then receive the SNGE intervention. Participants who were in the SNGE group during the first session will be re-evaluated and then receive the SNAG intervention. Following this second intervention, participants will be evaluated once again.
Assessments will be done are Demographic Form, Visual Analogue Scale, Oswestry Disability Index, Joint Range of Motion, Five-times Sit-to-stand Test, Sit and Reach Test
Eligibility criteria
Qualifiers
Adults between the ages of 20 and 50,
Individuals describing non-specific sciatic pain characterized by unilateral low back pain accompanied by radiating symptoms to the leg,
Duration of pain longer than 12 weeks,
Presence of pain during the Slump Test and Straight Leg Raise Test,
Disqualifiers
Individuals diagnosed with herniated disc or spinal stenosis by a physician,
Physician-diagnosed secondary neurological conditions,
History of spinal surgery,
Individuals describing the origin of their pain as the lower back (without leg involvement),
Trial design
Treatments tested in this trial
- Sustained Natural Apophyseal Glide (SNAG)
- Sciatic Nerve Mobilization Exercises (SNME)
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov